BIRC5 and neoplasm: Activation of the canonical WNT pathway has been described to affect proliferation and migration of various non-rhabdomyomatous tumor cells through induction of the targets such as the pro-proliferative protein MYC and the pro-proliferative and anti-apoptotic IAP-protein BIRC5 (survivin) (29, 30).